Polyp Detection Rate After Single Oral Dose of Methylene Blue MMX Modified Release Tablets Administered to Subjects Undergoing Outpatients Colonoscopy
NCT ID: NCT01520337
Last Updated: 2014-02-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
170 participants
OBSERVATIONAL
2012-01-31
2013-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neoplasia Detection With Methylene Blue MMX Tablets in Patients With UC Undergoing Colonoscopy
NCT01520324
Effect of Oral Administration of Methylene Blue MMX Tablets on Double Stranded DNA
NCT02295774
Panchromoendoscopy Using Oral Indigo Carmine Mixed With Polyethylene Glycol Prep
NCT01901510
Impact of Indigo Carmine Pump Spraying on the Adenoma Detection Rate
NCT06596317
Early Detection of Polyps and Colon Cancer by Fluorescence Imaging - a Dose-finding Study
NCT00285701
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
patients undergoing outpatient colonoscopy
oral tablet dye for detection of polyps during colonoscopy
oral tablet dye for improved detection of
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
oral tablet dye for detection of polyps during colonoscopy
oral tablet dye for improved detection of
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cosmo Technologies Ltd
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2011-005694-23
Identifier Type: EUDRACT_NUMBER
Identifier Source: secondary_id
CB-17-01/05
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.